Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Radiant Pharma (Pvt.) Ltd.,

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore pharmaceutical manufacturer incorporated in 2011 and operating a GMP/ISO-oriented manufacturing facility at Sundar Industrial Estate.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Radiant Pharma (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot No. 43-E, Sundar Industrial Estate, Raiwind-Lahore 53801, Pakistan · 53801
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000776 Radiant Pharma (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000776 50 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx51public portfolio records represented
REG42unique registrations represented
IDX50indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+1registry-only registrations
VER0registry-verified exact registrations
PKR48current validated price records
G22generic molecules in indexed catalogue
DF7dosage-form groups
TA5therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage94%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixRadiant Pharma (Pvt.) Ltd.,Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/radiant-pharma-pvt-ltdGenerated 23 Sep 2026Anti-infectives31 · 62%Oncology & immunology8 · 16%Gastrointestinal & hepatology4 · 8%Pain & musculoskeletal4 · 8%Vitamins, minerals & nutrition3 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioRadiant Pharma (Pvt.) Ltd.,Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/radiant-pharma-pvt-ltdGenerated 23 Sep 202650presentationsTablet20 · 40%Suspension11 · 22%Capsule7 · 14%Injection6 · 12%Syrup3 · 6%Solution2 · 4%Other forms1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionRadiant Pharma (Pvt.) Ltd.,Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/radiant-pharma-pvt-ltdGenerated 23 Sep 202648comparable productsBelow peer median11 · 23%Near peer median21 · 44%Above peer median16 · 33%Company median price position+2.7%Lowest-price equivalents2Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsRadiant Pharma (Pvt.) Ltd.,Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/radiant-pharma-pvt-ltdGenerated 23 Sep 2026Neutro Pharma (Pvt.) Ltd.,19 shared86% overlapSAMI Pharmaceuticals Pvt. Ltd.19 shared86% overlapM/s. Genix Pharma (Pvt) Ltd.17 shared77% overlapMacter International Limited17 shared77% overlapBio-Labs(Pvt) Ltd17 shared77% overlapPharmasol (Pvt) Ltd.16 shared73% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives31 products · 62%
Oncology & immunology8 products · 16%
Gastrointestinal & hepatology4 products · 8%
Pain & musculoskeletal4 products · 8%
Vitamins, minerals & nutrition3 products · 6%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Macrolide antibacterials8 products · 16%
Fluoroquinolone antibacterials7 products · 14%
Antivirals6 products · 12%
Antimalarials4 products · 8%
Analgesics / NSAIDs4 products · 8%
Antineoplastic medicines4 products · 8%
Immunosuppressants / immunomodulators4 products · 8%
Vitamins / minerals / hematinics3 products · 6%
Formulation footprint

Dosage forms

Tablet20 products
Suspension11 products
Capsule7 products
Injection6 products
Syrup3 products
Solution2 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 RadavirEntecavir 6presentations 0.05 mg/mL, 0.5 mg, 1 mg · Solution, Tablet #2 ApocineAzithromycin 5presentations 100 mg/5 mL, 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule, Tablet #3 RadifloxCiprofloxacin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #4 TacroverTacrolimus 4presentations 0.5 mg, 1 mg · Capsule #5 CalcimCalcium acetate 2presentations 667 mg · Tablet #6 ClithoradClarithromycin 2presentations 125 mg/5 mL, 500 mg · Suspension, Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1123% of comparable products
Near market median21within ±5% of median
Above market median1633% of comparable products
Lowest-price equivalents2ties included
Company median price position +2.7% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Vitamin D3 5 mg/mLCholecalciferol · Injection · 1's PKR 110.00/vial/unit-49.6% vs market median Radifluc 150 mgFluconazole · Capsule · 1's PKR 179.53/capsule-32.0% vs market median Radiflox 250 mg/5 mLCiprofloxacin · Dry suspension · 120ml PKR 3.88/mL-23.6% vs market median Apocine 250 mgAzithromycin · Tablet · 6's PKR 37.52/tablet-20.3% vs market median Apocin 500 mgAzithromycin · Injection · 1's PKR 398.94/vial/unit-19.3% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 19shared generics SAMI Pharmaceuticals Pvt. Ltd.194 products · 63 generics 19shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 17shared generics Macter International Limited256 products · 93 generics 17shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 17shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 16shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers41Distinct registrations among indexed, published, presentation-validated products only
Verified price observations50
Products with a verified price50
Products with multiple price observations0
Source records with multiple versions50
Latest portfolio source check22 Sep 2026
Latest effective price date4 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

42 unique registration(s) · 50 indexed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Apocin Azithromycin 500 mg Injection 1's 092263 PKR 398.94 PKR 398.94/vial/unit 19% below median
Apocine Azithromycin 200 mg/5 mL Dry suspension 15ml 074488 PKR 329.13 PKR 21.94/mL Near median
Apocine Azithromycin 250 mg Capsule 10's 074490 PKR 508.65 PKR 50.87/capsule Near median
Apocine Azithromycin 500 mg Tablet 6's 106046 PKR 412.68 PKR 68.78/tablet 19% below median
Apocine Azithromycin 250 mg Tablet 6's 106047 PKR 225.10 PKR 37.52/tablet 20% below median
Apocine Azithromycin 100 mg/5 mL Dry suspension 30ml 107082 PKR 150.07 PKR 5.00/mL 28% below median
Apozole Linezolid 100 mg/5 mL Suspension 60ml 093505 PKR 698.14 PKR 11.64/mL 6% above median
Calcim Calcium acetate 667 mg Tablet 30's 104601 PKR 149.83 PKR 4.99/tablet Near median
Calcim Calcium acetate 667 mg Tablet 100's 104601 PKR 499.43 PKR 4.99/tablet Near median
Clithorad Clarithromycin 125 mg/5 mL Dry suspension 60ml 074486 PKR 444.82 PKR 7.41/mL Near median
Clithorad Clarithromycin 500 mg Injection 1's 092270 PKR 270.12 PKR 270.12/vial/unit 58% above median
Omepran/Radiom Omeprazole 40 mg Capsule 2x7 077064 PKR 498.67 PKR 35.62/capsule Near median
R-CQP Chloroquine 250 mg Tablet 500's 106044 PKR 1,681.57 PKR 3.36/tablet 118% above median
R-CQP Chloroquine 50 mg/5 mL Syrup 60ml 106045 PKR 19.13 PKR 0.32/mL 5% below median
Radavir Entecavir 0.05 mg/mL Oral solution 120ml 093978 PKR 5,186.21 PKR 43.22/mL Near median
Radavir Entecavir 0.05 mg/mL Oral solution 210ml 093978 PKR 9,075.87 PKR 43.22/mL Near median
Radavir Entecavir 0.5 mg Tablet 30's 093979 PKR 9,827.86 PKR 327.60/tablet 8% below median
Radavir Entecavir 0.5 mg Tablet 10's 093979 PKR 3,560.53 PKR 356.05/tablet Near median
Radavir Entecavir 1 mg Tablet 30's 093980 PKR 16,378.45 PKR 545.95/tablet 8% below median
Radavir Entecavir 1 mg Tablet 10's 093980 PKR 5,934.23 PKR 593.42/tablet Near median
Radifen Ibuprofen 100 mg/5 mL Suspension 90ml 074478 PKR 79.13 PKR 0.88/mL 7% below median
Radifen Ibuprofen 600 mg Sachet 4's 088775 PKR 99.73 PKR 24.93/sachet 16% above median
Radiflox Ciprofloxacin 250 mg Tablet 10's 074471 PKR 259.32 PKR 25.93/tablet Near median
Radiflox Ciprofloxacin 500 mg Tablet 10's 074472 PKR 428.86 PKR 42.89/tablet Near median
Radiflox Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 099811 PKR 310.64 PKR 5.18/mL Near median
Radiflox Ciprofloxacin 250 mg/5 mL Dry suspension 120ml 099811 PKR 465.96 PKR 3.88/mL 24% below median
Radiflox Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 099812 PKR 222.36 PKR 3.71/mL Near median
Radifluc Fluconazole 150 mg Capsule 1's 074489 PKR 179.53 PKR 179.53/capsule 32% below median
Radifluc Dry Fluconazole 50 mg/5 mL Dry suspension 30ml 074487 PKR 418.88 PKR 13.96/mL 20% above median
Radifxon 1gm IM InjectionRegistry verified Ceftriaxone (as sodium) — — — 111958Official source ↗ No indexed price — —
Radilev Levofloxacin 250 mg Tablet 10's 074474 PKR 498.68 PKR 49.87/tablet Near median
Radilev Levofloxacin 500 mg Tablet 10's 074477 PKR 829.80 PKR 82.98/tablet Near median
Radilose Lactulose 3.35 g/5 mL Syrup 120ml 077077 PKR 295.22 PKR 2.46/mL Near median
Radimole Paracetamol 120 mg/5 mL Syrup 60ml 095705 PKR 66.01 PKR 1.10/mL Near median
Radimole 6 Plus Paracetamol 250 mg/5 mL Suspension 60ml 074485 PKR 94.97 PKR 1.58/mL Near median
Radimthar Artemether + Lumefantrine 20 mg + 120 mg Tablet 2x8 074475 PKR 638.30 PKR 39.89/tablet Near median
Radimthar Artemether 40 mg Tablet 8's 076954 PKR 526.60 PKR 65.83/tablet 6% above median
Radimthar Omeprazole 20 mg Tablet 14's 077063 PKR 287.23 PKR 20.52/tablet 8% above median
Radiom Omeprazole 40 mg Injection 1's 092262 PKR 598.41 PKR 598.41/vial/unit 7% above median
Radisulf Sulfamethoxazole 200 mg/5 mL Oral suspension 50ml 074480 PKR 27.55 PKR 0.55/mL No comparator
Retzole Letrozole 2.5 mg Tablet 30's 093984 PKR 14,094.71 PKR 469.82/tablet 17% above median
Retzole Letrozole 2.5 mg Tablet 10's 093984 PKR 4,698.24 PKR 469.82/tablet 17% above median
Roz Anastrozole 1 mg Tablet 30's 093981 PKR 11,010.72 PKR 367.02/tablet 8% above median
Roz Anastrozole 1 mg Tablet 10's 093981 PKR 3,989.40 PKR 398.94/tablet 17% above median
Tacrover Tacrolimus 1 mg Capsule 30's 093982 PKR 3,119.50 PKR 103.98/capsule 7% above median
Tacrover Tacrolimus 1 mg Capsule 10's 093982 PKR 1,130.25 PKR 113.03/capsule 16% above median
Tacrover Tacrolimus 0.5 mg Capsule 30'z 093983 PKR 1,871.70 — No comparator
Tacrover Tacrolimus 0.5 mg Capsule 10's 093983 PKR 678.15 PKR 67.82/capsule 19% above median
Vanco Vancomycin 500 mg Injection 1's 092268 PKR 1,396.29 PKR 1,396.29/vial/unit 16% above median
Varitex Voriconazole 200 mg Injection 1's 092269 PKR 1,496.02 PKR 1,496.02/vial/unit Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Radiant Pharma (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/radiant-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.